Development of alopecia in patients treated with interleukin‐17 inhibitors
- 11 November 2020
- journal article
- letter
- Published by Wiley in Dermatologic Therapy
- Vol. 33 (6) , e14527
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Ixekizumab-induced alopecia areataJAAD Case Reports, 2020
- New onset alopecia areata during secukinumab therapyDermatologic Therapy, 2019
- Alopecia Diffusa while Using Interleukin-17 Inhibitors against Psoriasis VulgarisCase Reports in Dermatology, 2019
- Efficacy and safety of secukinumab treatment in adults with extensive alopecia areataArchives of Dermatological Research, 2018
- IL-17 inhibition: is it the long-awaited savior for alopecia areata?Archives of Dermatological Research, 2018
- Alopecia areata occurring during anti-TNF therapy: A national multicenter prospective studyJournal of the American Academy of Dermatology, 2014
- The association of psoriasis with autoimmune diseasesJournal of the American Academy of Dermatology, 2012
- Renbök Phenomenon and Contact Sensitization in a Patient With Alopecia UniversalisArchives of Dermatology, 2010